A Systematic Analysis of a Potential Metabolism-related Prognostic Signature for Breast Cancer Patients

Overview

Journal Ann Transl Med

Publisher AME Publishing Company

Date 2021 Mar 12

PMID 33708957

Citations 3

Authors

Shibo Yu

Xiaowen Wang

Lizhe Zhu

Peiling Xie

Yudong Zhou

Siyuan Jiang

Heyan Chen

Xiaoqin Liao

Shengyu Pu

Zhenzhen Lei

Bin Wang

Yu Ren

Affiliations

Soon will be listed here.

Abstract

Background: Metabolic pathways play an essential role in breast cancer. However, the role of metabolism-related genes in the early diagnosis of breast cancer remains unknown.

Methods: In our study, RNA sequencing (RNA-seq) expression data and clinicopathological information from The Cancer Genome Atlas (TCGA) and GSE20685 were obtained. Univariate cox regression and least absolute shrinkage and selection operator (LASSO) regression analyses were performed on the differentially expressed metabolism-related genes. Then, the formula of the metabolism-related risk model was composed, and the risk score of each patient was calculated. The breast cancer patients were divided into high-risk and low-risk groups with a cutoff of the median expression value of the risk score, and the prognostic analysis was also used to analyze the survival time between these two groups. In the end, we also analyzed the expression, interaction, and correlation among genes in the metabolism-related gene risk model.

Results: The results from the prognostic analysis indicated that the survival was significantly poorer in the high-risk group than in the low-risk group in both TCGA and GSE20685 datasets. In addition, after adjusting for different clinicopathological features in multivariate analysis, the metabolism-related risk model remained an independent prognostic indicator in TCGA dataset.

Conclusions: In summary, we systematically developed a potential metabolism-related gene risk model for predicting prognosis in breast cancer patients.

Citing Articles

A prediction model for prognosis of gastric adenocarcinoma based on six metabolism-related genes.

Zhao J, Liu Y, Cui Q, He R, Zhao J, Lu L Biochem Biophys Rep. 2023; 34:101440.

PMID: 36852096 PMC: 9957706. DOI: 10.1016/j.bbrep.2023.101440.

Increased Expression of QPRT in Breast Cancer Infers a Poor Prognosis and Is Correlated to Immunocytes Infiltration.

Zhang Q, Ding X, Lu H J Healthc Eng. 2022; 2022:6482878.

PMID: 35345651 PMC: 8957413. DOI: 10.1155/2022/6482878.

Signature based on metabolic-related gene pairs can predict overall survival of osteosarcoma patients.

Li L, Zhang L, Yuan Y, Lu X, Zhang Y, Liu Y Cancer Med. 2021; 10(13):4493-4509.

PMID: 34047495 PMC: 8267140. DOI: 10.1002/cam4.3984.

References

Zhu Z, Leung G . More Than a Metabolic Enzyme: MTHFD2 as a Novel Target for Anticancer Therapy?. Front Oncol. 2020; 10:658. PMC: 7199629. DOI: 10.3389/fonc.2020.00658. View

Meng M, Chen Y, Jia J, Li L, Yang S . Knockdown of PAICS inhibits malignant proliferation of human breast cancer cell lines. Biol Res. 2018; 51(1):24. PMC: 6086025. DOI: 10.1186/s40659-018-0172-9. View

Wang F, Tang C, Gao X, Xu J . Identification of a six-gene signature associated with tumor mutation burden for predicting prognosis in patients with invasive breast carcinoma. Ann Transl Med. 2020; 8(7):453. PMC: 7210212. DOI: 10.21037/atm.2020.04.02. View

Rosa Mendoza E, Moreno E, Caguioa P . Predictors of early distant metastasis in women with breast cancer. J Cancer Res Clin Oncol. 2013; 139(4):645-52. DOI: 10.1007/s00432-012-1367-z. View

Thompson N, Storr S, Zhang S, Martin S . Lymphovascular invasion: assessment and prognostic impact in melanoma and breast cancer. Histol Histopathol. 2015; 30(9):1001-9. DOI: 10.14670/HH-11-615. View

Ritchie M, Phipson B, Wu D, Hu Y, Law C, Shi W . limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015; 43(7):e47. PMC: 4402510. DOI: 10.1093/nar/gkv007. View

Goodwin S, McPherson J, McCombie W . Coming of age: ten years of next-generation sequencing technologies. Nat Rev Genet. 2016; 17(6):333-51. PMC: 10373632. DOI: 10.1038/nrg.2016.49. View

Flentie K, Gonzalez C, Kocher B, Wang Y, Zhu H, Marasa J . Nucleoside Diphosphate Kinase-3 () Enhances TLR5-Induced NFB Activation. Mol Cancer Res. 2018; 16(6):986-999. DOI: 10.1158/1541-7786.MCR-17-0603. View

Aryal B, Rao V . Specific protein carbonylation in human breast cancer tissue compared to adjacent healthy epithelial tissue. PLoS One. 2018; 13(3):e0194164. PMC: 5875748. DOI: 10.1371/journal.pone.0194164. View

10.

Lin Q, Liu W, Mo Y, Han J, Guo Z, Zheng W . Development of prognostic index based on autophagy-related genes analysis in breast cancer. Aging (Albany NY). 2020; 12(2):1366-1376. PMC: 7053636. DOI: 10.18632/aging.102687. View

11.

Ullmark T, Montano G, Jarvstrat L, Nilsson H, Hakansson E, Drott K . Anti-apoptotic quinolinate phosphoribosyltransferase (QPRT) is a target gene of Wilms' tumor gene 1 (WT1) protein in leukemic cells. Biochem Biophys Res Commun. 2016; 482(4):802-807. DOI: 10.1016/j.bbrc.2016.11.114. View

12.

Koukourakis M, Giatromanolaki A, Harris A, Sivridis E . Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res. 2006; 66(2):632-7. DOI: 10.1158/0008-5472.CAN-05-3260. View

13.

Fischer K, Hoffmann P, Voelkl S, Meidenbauer N, Ammer J, Edinger M . Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood. 2007; 109(9):3812-9. DOI: 10.1182/blood-2006-07-035972. View

14.

Goonesekere N, Andersen W, Smith A, Wang X . Identification of genes highly downregulated in pancreatic cancer through a meta-analysis of microarray datasets: implications for discovery of novel tumor-suppressor genes and therapeutic targets. J Cancer Res Clin Oncol. 2017; 144(2):309-320. DOI: 10.1007/s00432-017-2558-4. View

15.

Marangoni E, Laurent C, Coussy F, El-Botty R, Chateau-Joubert S, Servely J . Capecitabine Efficacy Is Correlated with TYMP and RB1 Expression in PDX Established from Triple-Negative Breast Cancers. Clin Cancer Res. 2018; 24(11):2605-2615. DOI: 10.1158/1078-0432.CCR-17-3490. View

16.

Yang J, Kong P, Yang J, Jia Z, Hu X, Wang Z . High TSTA3 Expression as a Candidate Biomarker for Poor Prognosis of Patients With ESCC. Technol Cancer Res Treat. 2018; 17:1533033818781405. PMC: 6048620. DOI: 10.1177/1533033818781405. View

17.

Xia W, Xie L, Cao B, Cheng S, Wan H, Liu H . Genes involved in leukotriene synthesis pathway are dynamically regulated during lung development in Rhesus monkeys. Prostaglandins Leukot Essent Fatty Acids. 2017; 122:1-6. DOI: 10.1016/j.plefa.2017.06.008. View

18.

Chen Z, Li Z, Li H, Jiang Y . Metabolomics: a promising diagnostic and therapeutic implement for breast cancer. Onco Targets Ther. 2019; 12:6797-6811. PMC: 6709037. DOI: 10.2147/OTT.S215628. View

19.

Siegel R, Miller K, Jemal A . Cancer statistics, 2020. CA Cancer J Clin. 2020; 70(1):7-30. DOI: 10.3322/caac.21590. View

20.

Feng X, Tang R, Zhang R, Wang H, Ji Z, Shao Y . A comprehensive analysis of IDO1 expression with tumour-infiltrating immune cells and mutation burden in gynaecologic and breast cancers. J Cell Mol Med. 2020; 24(9):5238-5248. PMC: 7205837. DOI: 10.1111/jcmm.15176. View